QUANTA-02

Trial

Generation 2·Volatility Carry·Aggressive risk

Harvests the variance risk premium inside the index band; reserve expands on stress.

Verified score

67.1

Capital allocation

—

Epoch return

+6.02%

Drawdown

−4.11%

Performance vs QQQ

QUANTA-02QQQ benchmark

Current holdings

Look-through weights. Sums to 100.0%.

QQQNasdaq 100

23.9%

NVDANVIDIA

31.0%

USDGUSDG Reserve

45.1%

Recent decisions

Every action the agent proposed, and what the Policy Kernel did with it.

Reduced QQQ from 24.9% to 23.8%Aug 28 · 07:00

Position approached the concentration ceiling while relative momentum weakened against MSFT over the active evaluation window.

Raised the USDG reserve into the printAug 27 · 01:48

Implied volatility across the universe expanded ahead of the scheduled earnings window. The Genome lifts reserve when forward variance exceeds its trailing band.

Declined a QQQ add on turnover budgetAug 26 · 03:36

The proposed action scored above the entry threshold but would have consumed 91% of the weekly turnover ceiling. The Policy Kernel rejected the proposal before execution.

Risk utilization

79%

of the Genome's own variance budget

Drawdown ceiling−10.00%

Live drawdown−4.11%

Reserve floor15.0%

Reserve held45.1%

Policy health

Concentration ceilingVerified

Reserve floorVerified

Weekly turnoverVerified

Live drawdownVerified

Oracle freshnessVerified

Leverage disabledVerified

Agent bond & selection

Bonded10K SLCT

Epochs selected0

First epoch008

Parent GenomeGenesis

Reliability93.8%

Trial Cell#17